DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,000 | -99.1% | 161 | -93.7% | 0.00% | -100.0% |
| Q1 2021 | $117,000 | +101.7% | 2,551 | +121.4% | 0.01% | +50.0% |
| Q3 2020 | $58,000 | -32.6% | 1,152 | -19.8% | 0.00% | -33.3% |
| Q2 2020 | $86,000 | +230.8% | 1,436 | +127.2% | 0.01% | +200.0% |
| Q1 2020 | $26,000 | -81.6% | 632 | -72.1% | 0.00% | -77.8% |
| Q4 2019 | $141,000 | +2720.0% | 2,262 | +1368.8% | 0.01% | – |
| Q3 2019 | $5,000 | -99.6% | 154 | +340.0% | 0.00% | – |
| Q2 2018 | $1,377,000 | +137600.0% | 35 | -7.9% | 0.00% | – |
| Q1 2018 | $1,000 | – | 38 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $11,213,000 | 5.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,580,456 | $51,731,000 | 1.16% |
| ARMISTICE CAPITAL, LLC | 5,836,000 | $54,100,000 | 1.05% |
| Pinz Capital Management, LP | 165,835 | $1,537,000 | 0.96% |
| Sunesis Advisors, LLC | 96,299 | $893,000 | 0.52% |
| Redmile Group, LLC | 664,817 | $6,163,000 | 0.19% |
| PDT Partners, LLC | 222,343 | $2,061,000 | 0.18% |
| Bayesian Capital Management, LP | 41,900 | $388,000 | 0.06% |
| Laurion Capital Management LP | 459,290 | $4,258,000 | 0.05% |
| Hennion & Walsh Asset Management, Inc. | 101,643 | $942,000 | 0.05% |